New study to have impact on federal drug safety system

Share this content:

The upcoming release of a new report could lead to a new way of monitoring prescription drug safety, according to officials at the Food and Drug Administration.

The Institute of Medicine is currently wrapping up its evaluation of the Food and Drug Administration's current system for monitoring drug safety. The evaluation is expected to have "a profound influence on future drug safety laws," said Paul J. Seligman, associate director for safety policy and communication at FDA's Center for Drug Evaluation and Research.

The IOM's report, due later this summer or early fall, is part of a drug safety initiative the FDA launched in 2005 to make timely drug safety information available to the public and healthcare professionals. Last month, the FDA said it plans to create a new electronic system for collecting adverse event reports on medications and medical devices.